First human test for new heart pill
NCT ID NCT07186946
Summary
This was a very early safety study for a new drug called THRV-1268, which is being developed for heart failure. Researchers gave single doses to 16 healthy but obese adults to see if it was safe and to measure how the body processes it. The main goal was to check for side effects and understand how the drug moves through the body, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.